5/17
07:44 am
abbv
AbbVie Inc. (NYSE: ABBV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $200.00 price target on the stock.
Low
Report
AbbVie Inc. (NYSE: ABBV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $200.00 price target on the stock.
5/17
07:15 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
5/17
06:09 am
abbv
AbbVie initiated with bullish view at Cantor Fitzgerald
Low
Report
AbbVie initiated with bullish view at Cantor Fitzgerald
4/29
11:25 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
4/29
11:25 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
4/29
10:08 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
4/29
10:08 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
3/27
07:46 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
3/27
07:46 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
3/22
02:01 pm
abbv
Rating for ABBV
Low
Report
Rating for ABBV
3/22
02:01 pm
abbv
Rating for ABBV
Low
Report
Rating for ABBV